- Spain holds > 95% of the European breeding population of the Eurasian griffon vulture Gyps fulvus. Vultures provide important ecosystem services in carcass removal and influence emissions of greenhouse gases. Despite the known toxicity of the non-steroidal anti-inflammatory drug diclofenac to this species and other Gyps vultures, in March 2013 the Agencia Española de Medicamentos y Productos Sanitarios (AEMPS) approved the use of two medicines containing diclofenac for veterinary use in horses, pigs and cattle in Spain.
- To assess the potential impact of medicated ungulate carcasses on Eurasian griffon vulture populations in Spain, we first used information on the metabolism and elimination of diclofenac from medicated cattle and pigs to calculate residue levels in relation to time elapsed between dosing and death. Secondly, probabilities of the death of a vulture per meal were calculated based upon experimental studies of diclofenac toxicity. Finally, annual numbers of vulture deaths expected to be caused by diclofenac were obtained by multiplying the death rates per meal by the estimated numbers of vulture meals taken from expected numbers of medicated carcasses suggested by AEMPS.
- Assuming that vultures feed on carcasses that were treated with diclofenac 8 h before the animal's death, the annual number of vulture deaths caused by diclofenac was estimated at 715–6389, depending upon the estimate of numbers of medicated carcasses assumed and the version of the dose–response model used. Using a density-independent simulation model of a vulture population, the expected rate of decline of the Spanish population of Eurasian griffon vultures caused by these deaths is 0·9–7·7% per year. A density-dependent simulation model also indicated substantial population-level effects. Formal estimates of precision and sensitivity analyses of effects of unmeasured variables highlight the uncertainty of estimates using currently available data.
- Synthesis and applications. Due to the possibility of causing an important impact on vulture populations, our findings justify a precautionary ban on the veterinary use of diclofenac in Spain and encourage the use of meloxicam, a vulture-safe alternative drug. A programme of monitoring of non-steroidal anti-inflammatory drug contamination of ungulate carcasses available to vultures and of moribund and dead obligate and facultative avian scavengers would be needed to be confident that a damaging level of contamination is not present.